Literature DB >> 16943722

Glycaemic control in critically ill patients with cardiovascular disease.

Andrew O Wade1, Jeremy J Cordingley.   

Abstract

PURPOSE OF REVIEW: The role of hyperglycaemia in the pathogenesis of myocardial damage during cardiac surgery or patients with acute coronary syndromes has been the subject of increasing interest over the past few years. Several further trials and meta-analyses investigating the role of insulin treatment, either aimed at tight control of blood glucose concentration or as part of a regimen including glucose and potassium, have been reported recently and are the subject of this review. RECENT
FINDINGS: Good control of blood glucose has been demonstrated to improve outcomes for diabetic patients undergoing cardiac surgery and following acute myocardial infarction. In surgical intensive care patients, tight glucose control improved mortality--a finding that is awaiting confirmation in multicentre studies. The use of glucose-insulin-potassium regimens does not improve outcomes in patients with acute myocardial infarction who have undergone reperfusion therapy, but may be beneficial during cardiac surgery.
SUMMARY: Tight control of blood glucose has been shown to be beneficial in several patient groups. The optimal target glucose concentration and glucose and insulin regimens remain to be confirmed or determined in each clinical situation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943722     DOI: 10.1097/01.ccx.0000244123.39247.b9

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  3 in total

1.  Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study.

Authors:  Richard Engbersen; Niels P Riksen; Marc J Mol; Bert Bravenboer; Otto C Boerman; Patrick Meijer; Wim J G Oyen; Cees Tack; Gerard A Rongen; Paul Smits
Journal:  Cardiovasc Diabetol       Date:  2012-10-10       Impact factor: 9.951

2.  Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus.

Authors:  Milan Flekac; Jan Skrha; Jirina Hilgertova; Zdena Lacinova; Marcela Jarolimkova
Journal:  BMC Med Genet       Date:  2008-04-21       Impact factor: 2.103

3.  Change in the perioperative blood glucose and blood lactate levels of non-diabetic patients undergoing coronary bypass surgery.

Authors:  Chunjian Shen; Tianxiang Gu; Lili Gu; Zhongyi Xiu; Zhiwei Zhang; Enyi Shi; Yuhai Zhang; Chun Wang
Journal:  Exp Ther Med       Date:  2013-08-22       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.